Current Report Filing (8-k)

false 0001156375 0001156375 2020-03-20 2020-03-20

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported) March 20, 2020

 

CME GROUP INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware		001-31553		36-4459170
(State or Other Jurisdiction of Incorporation)		(Commission File No.)		(IRS Employer Identification No.)

20 South Wacker Drive, Chicago, Illinois		60606
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: [phone]

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading symbol		Name of each exchange on which registered
Class A Common Stock		CME		Nasdaq

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

---

Item 7.01

Regulation FD Disclosure

On March 20, 2020, as described in the press release attached as Exhibit 99.1, pursuant to its rules, CME Clearing completed an auction of portfolios of Ronin Capital, LLC (“Ronin”). Though Ronin was a direct clearing member, it did not handle customer business. Today, CME Group Inc. confirms that there was no impact to the guaranty fund of Chicago Mercantile Exchange Inc. nor were there any customers or clearing members impacted. Any remaining margin and guaranty fund of Ronin, after costs, will be returned to Ronin. CME Clearing is a Division of Chicago Mercantile Exchange Inc., which is a wholly-owned subsidiary of CME Group Inc.

The information in this Item 7.01 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in this Item 7.01 of this Current Report on Form 8-K shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 8.01

Other Events

The disclosure under Item 7.01 (Regulation FD Disclosure) is incorporated herein by reference.

Item 9.01

Financial Statements and Exhibits

Exhibit Number				Description
	99.1			Press Release, dated March 20, 2020
	104			The cover page from CME Group Inc.’s Current Report on Form 8-K, formatted in Inline XBRL.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

				CME Group Inc.
				Registrant
Date: March 24, 2020				By:		/s/ Kathleen M. Cronin
				Name:		Kathleen M. Cronin
				Title:		Senior Managing Director, General Counsel and Corporate Secretary